Rock Springs Capital Management LP Solid Biosciences Inc. Transaction History

Rock Springs Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$4.6 - $10.13 $276,000 - $607,800	-60,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.19 - $32.37 $7,197 - $32,402	1,001 Added 1.7%	60,000 $552,000
Q4 2018 Feb 14, 2019	SELL	$21.32 - $46.34 $767,541 - $1.67 Million	-36,001 Reduced 37.9%	58,999 $1.58 Million
Q2 2018 Aug 14, 2018	SELL	$7.33 - $43.15 $219,900 - $1.29 Million	-30,000 Reduced 24.0%	95,000 $3.39 Million
Q1 2018 May 15, 2018	BUY	$7.19 - $33.17 $898,750 - $4.15 Million	125,000 New	125,000 $938,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $35.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.